Form4insider filings, from the source

SEC Form 4 · accession 0001225208-15-005740

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Karen Prange
Officer — SVP&Pres, Uro & Women's Health
Period of report
Feb 23, 2015
Accepted (ET)
Feb 25, 2015 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Deferred Stock UnitsF1,F2—Feb 23, 2015A11,496A—Feb 23, 2020Common Stock11,49611,496D
Performance Share UnitsF4,F3—Feb 23, 2015A10,701ADec 31, 2016Dec 31, 2016Common Stock10,70110,701D
Stock Option (Right to Buy)F5$16.31Feb 23, 2015A32,327A—Feb 23, 2025Common Stock32,32732,327D

Explanation of responses